Everolimus in combination with T-DM1 showed strong antitumor effects in HER2-positive breast cancer, both in vitro and in vivo.
[Molecular Cancer Research]
6445212
AAAAAAAA
items
1
apa
0
default
asc
1
173497
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
